Mariner Investment Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mariner Investment Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-28,400	Closed	-$4.01M	–	110
2016 Q2	$4.01M	Sell	28,400 -16,600	-37%	-$2.45M	1.36%	27
2016 Q1	$5.88M	Hold	45,000	–	–	1.62%	15
2015 Q4	$6.33M	Buy	45,000 +9,100	+25%	+$1.26M	1.41%	14
2015 Q3	$4.77M	Buy	35,900 +9,000	+33%	+$1.55M	0.96%	31
2015 Q2	$4.74M	Buy	26,900 +6,000	+29%	+$1.08M	1.21%	18
2015 Q1	$3.61M	Sell	20,900 -7,200	-26%	-$1.24M	0.97%	33
2014 Q4	$4.6M	Buy	28,100 +3,000	+12%	+$498K	0.78%	31
2014 Q3	$4.03M	Buy	25,100 +2,300	+10%	+$354K	0.83%	30
2014 Q2	$3.35M	Buy	22,800 +5,000	+28%	+$693K	0.65%	38
2014 Q1	$2.47M	Buy	+17,800	New	+$2.68M	0.54%	44

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mariner Investment Group's JAZZ Position: Q3 2016 in Review

Mariner Investment Group sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2016, closing a stake of 28,400 shares — an estimated $4.01M sold.

Mariner Investment Group first reported a position in JAZZ in Q1 2014 and held it in 10 quarters. The position peaked at $6.33M in Q4 2015. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

Mariner Investment Group reported no remaining Jazz Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Mariner Investment Group sold 28,400 Jazz Pharmaceuticals shares in Q3 2016, an estimated $4.01M.
Mariner Investment Group first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 10 quarters.
Mariner Investment Group's Jazz Pharmaceuticals position peaked at $6.33M in Q4 2015.
325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.